Research Topics
| Parsia A VagefiSummaryAffiliation: University of California Country: USA Publications
| Collaborators |
Detail Information
Publications
Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy?Parsia A Vagefi
Division of Transplantation, University of California, San Francisco, CA 94143, USA
J Gastrointest Cancer 41:217-20. 2010..We present a patient with HCC who underwent treatment with sorafenib, which resulted in a remarkable reduction in tumor burden to allow for liver transplant listing...
Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and reviewParsia A Vagefi
Division of Transplant Surgery, University of California, San Francisco, San Francisco, CA 94143, USA
J Gastrointest Surg 15:209-14. 2011..The optimal surgical management of symptomatic hepatic hemangiomas remains controversial, with resection, enucleation, and both deceased donor and living donor liver transplantation having been reported...
Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010Parsia A Vagefi
Division of Transplant Surgery, Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA
Arch Surg 146:1052-9. 2011..Split liver transplantation (SLT) allows for expansion of the deceased donor pool...
Use of living donor liver transplantation varies with the availability of deceased donor liver transplantationParsia A Vagefi
Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
Liver Transpl 18:160-5. 2012..These differences can be hypothesized to be driven in part by the relative availability of LDLT versus DDLT at both the patient level and the DSA level...
